The Heightened COVID-19 Threat for People Living with HIV
Professor Giulia Marchetti's team found that unvaccinated people with HIV hospitalised with COVID-19 had more virus in their blood, skewed T-cell responses and stronger inflammation than others.
Read the original paper
While COVID-19 has challenged healthcare systems worldwide, its impact on individuals with pre-existing conditions like HIV has sparked particular concern. People living with HIV are often at a higher risk for various infections, raising critical questions about their resilience against SARS-CoV-2. This concern stems from the complex interplay between their compromised immune systems and the intrinsically aggressive nature of COVID-19, especially in unvaccinated individuals,making the exploration of this intersection a public health priority.
As the world grapples with the ongoing challenges of the COVID-19 pandemic, a recent study published in the journal iScience, led by Prof. Giulia Marchetti from the University of Milan, delves into the exacerbated risks faced by people living with HIV (PLWH) who contract COVID-19. This research uncovers how SARS-CoV-2 RNAemia, skewed T cell responses, and inflammation amplify the severity of COVID-19 in this vulnerable population.
Prof. Marchetti explains the severity of the immune dysfunction: “PLWH displayed a significantly higher RNAemia than HIV-negative individuals, indicating a greater replication and potentially systemic dissemination of the virus in PLWH.” She adds, “We found a clear separation between PLWH and HIV-negative individuals based on principal component analysis of plasma cytokines, suggesting an exacerbated inflammatory response to SARS-CoV-2 in PLWH.” These insights provide a deeper understanding of the unique challenges faced by PLWH during the COVID-19 pandemic.
The study employed a cross-sectional design, recruiting both unvaccinated PLWH and age/sex-matched HIV-negative individuals. Methods such as flow cytometry, ELISA, and cytometric bead array were used to analyze SARS-CoV-2–specific T-cell and humoral responses as well as a panel of plasma cytokines. This approach provided a detailed view of how the immune system of unvaccinated PLWH uniquely responds to SARS-CoV-2 infection.
Despite relatively preserved humoral immunity, PLWH exhibited fewer and less polyfunctional SARS-CoV-2-specific T cells, pointing to a compromised adaptive immune response to the virus. The peculiar cytokine profile in PLWH was marked by elevated levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-4 (IL-4), and tumor necrosis factor-alpha (TNF-α), with reduced levels of interleukin-2 (IL-2) and IL-9. These findings indicate a more severe cytokine storm in PLWH, correlating with more severe respiratory insufficiency.
To further contextualize the importance of this study, it is essential to consider the broader implications for public health policies and clinical practices. The findings underscore the necessity for proactive health measures tailored specifically for PLWH during pandemic conditions. This includes not only the development of more effective therapeutic interventions but also enhanced screening and prevention strategies to manage potential outbreaks. Ensuring that these individuals receive vaccinations promptly and are monitored closely for COVID-19 symptoms could significantly reduce hospitalization rates and improve outcomes. Integrating these preventive measures with existing HIV care programs could provide a dual benefit, reinforcing the health infrastructure needed to protect this high-risk population during ongoing and future health crises.
These profound implications, as highlighted by Prof. Giulia Marchetti and her team, underscore the urgent need for tailored clinical strategies to effectively manage SARS-CoV-2 infection in PLWH. Prof. Marchetti suggests that enhanced surveillance and possibly early therapeutic strategies are crucial to mitigate the severe impacts observed in this vulnerable population.
About the researchers
Journal reference
Augello, Matteo; Bono, Valeria; Rovito, Roberta; et al. “Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV.” iScience, January 19, 2024. DOI: https://doi.org/10.1016/j.isci.2023.108673






